Respiratory/Pulmonary market research reports by DelveInsight

• BRAF Mutated Non-small Cell Lung Cancer (NSCLC) – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  BRAF Mutated Non-small Cell Lung Cancer (NSCLC) – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""BRAF Mutated Non-small Cell Lung Cancer (NSCLC) – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the BRAF Mutated Non- ... Read More

• Chronic Bronchitis – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Chronic Bronchitis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Chronic Bronchitis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Chronic Bronchitis, historical and forecasted epidemiology as well as the C ... Read More

• Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Autoimmune pulmonary alveolar proteinosis (aPAP) - Pipeline Insight, 2024 Autoimmune pulmonary alveolar proteinosis (aPAP) Overview ""Autoimmune pulmonary alveolar proteinosis (aPAP) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenar ... Read More

• Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Acute Respiratory Distress Syndrome (ARDS) - Pipeline Insight, 2024 DelveInsight’s, “Acute Respiratory Distress Syndrome – Pipeline Insight, 2024,” report provides comprehensive insights about 120+ companies and 120+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers ... Read More

• Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 3,000

  Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2024 DelveInsight’s, “Idiopathic Pulmonary Fibrosis - Pipeline Insight, 2024” report provides comprehensive insights about 80+ companies and 100+ pipeline drugs in Idiopathic Pulmonary Fibrosis pipeline landscape. It covers the pipeline drug profiles ... Read More

• Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection - Pipeline Insight, 2024 Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Overview ""Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insig ... Read More

• Acute Lung Injury - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Acute Lung Injury - Pipeline Insight, 2024 Acute Lung Injury Overview ""Acute Lung Injury Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Acute Lung Injury market. A detailed picture of the Acute ... Read More

• Cough in Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Cough in Idiopathic Pulmonary Fibrosis (IPF) - Pipeline Insight, 2024 Cough in Idiopathic Pulmonary Fibrosis (IPF) Overview ""Cough in Idiopathic Pulmonary Fibrosis (IPF) Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growt ... Read More

• Pulmonary Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 4,250

  Pulmonary Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Pulmonary Drugs Market By Drug Class (Beta-2 Agonists, Corticosteroids, Anticholinergic Agents, Antihistamines, And Others), Indication (Asthma, Chronic Obstructive Pulmonary Disorder (COPD), Cystic Fibrosis, ... Read More

• Acute Respiratory Distress Syndrome- Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 2,500

  Acute Respiratory Distress Syndrome- Pipeline Insight, 2024 DelveInsight’s, “Acute Respiratory Distress Syndrome- Pipeline Insight, 2024” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Acute Respiratory Distress Syndrome pipeline landscape. It covers the pipelin ... Read More

• Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Pulmonary Arterial Hypertension Market Insight, Epidemiology And Market Forecast - 2034 Key Highlights In 2023, the market size of myelofibrosis was highest in the US among the 7MM, accounting for approximately USD 1,400 million, which is further expected to increase by 2034. In the 7MM, JAKAFI/JAKA ... Read More

• Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast– 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Cough in Idiopathic Pulmonary Fibrosis (IPF) - Epidemiology Forecast– 2034 Key Highlights According to DelveInsight’s estimates in 2022, the total diagnosed prevalent cases of Cough in IPF in the 7MM were nearly 148,000 in 2022, which is expected to increase by 2034 due to improved awareness, aging ... Read More

• Cough in Idiopathic pulmonary fibrosis (IPF) – Market Insights, Epidemiology, and Market Forecast – 2034

  Jan 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Cough in Idiopathic pulmonary fibrosis (IPF) – Market Insights, Epidemiology, and Market Forecast – 2034 Key Highlights The Cough in IPF market is projected to witness consistent growth throughout the forecast period (2023–2034). The market size of Cough in IPF in the 7MM is expected to increase, dr ... Read More

• Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023

  Jul 01, 2023  |  Published by: DelveInsight  |  USD 2,500

  Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023 DelveInsight’s, “Chronic Obstructive Pulmonary Disease - Pipeline Insight, 2023” report provides comprehensive insights about 65+ companies and 70+ pipeline drugs in Chronic Obstructive Pulmonary Disease pipeline landscape. It covers the ... Read More

• Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2023

  Mar 01, 2023  |  Published by: DelveInsight  |  USD 1,500

  Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2023 DelveInsight’s, “Non‐cystic fibrosis bronchiectasis - Pipeline Insight, 2023” report provides comprehensive insights about 16+ companies and 17+ pipeline drugs in Non‐cystic fibrosis bronchiectasis pipeline landscape. It covers the pipeline ... Read More

• Therapeutic Respiratory Devices- Market Insights, Competitive Landscape, and Market Forecast - 2027

  Feb 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  Therapeutic Respiratory Devices- Market Insights, Competitive Landscape, and Market Forecast - 2027 Therapeutic Respiratory Devices Market By Product (Positive Airway Pressure Devices {Continuous Positive Airway Pressure Devices, Auto-Titrating Positive Airway Pressure Devices, Bi-Level Positive Air ... Read More

• Respiratory Syncytial Virus (RSV) - Market Insight, Epidemiology And Market Forecast - 2032

  Jan 01, 2023  |  Published by: DelveInsight  |  USD 7,500

  Respiratory Syncytial Virus (RSV) - Market Insight, Epidemiology And Market Forecast - 2032 DelveInsight’s “Respiratory syncytial virus (RSV) — Market Insights, Epidemiology, and Market Forecast — 2032” report delivers an in-depth understanding of the RSV, historical and forecasted epidemiology as w ... Read More

• Neonatal respiratory distress syndrome - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Neonatal respiratory distress syndrome - Pipeline Insight, 2022 DelveInsight’s, “Neonatal respiratory distress syndrome - Pipeline Insight, 2022,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Neonatal respiratory distress syndrome pipeline landscape. It covers t ... Read More

• Mesothelioma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Mesothelioma - Pipeline Insight, 2022 DelveInsight’s, “Mesothelioma - Pipeline Insight, 2022,” report provides comprehensive insights about 50+ companies and 50+ pipeline drugs in Mesothelioma pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products ... Read More

• Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2022 DelveInsight’s, “Bronchiolitis Obliterans Syndrome - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Bronchiolitis Obliterans Syndrome pipeline landscape. It covers the pipeline dr ... Read More

• Breath Analyzers Market Insights, Competitive Landscape and, Market Forecast - 2027

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,750

  Breath Analyzers Market Insights, Competitive Landscape and, Market Forecast - 2027 BREATH ANALYZERS MARKET BY TYPE (DEVICE AND CONSUMABLES [MOUTH PIECE, CABLES AND ADAPTERS, AND OTHERS]), BY TECHNOLOGY (FUEL CELL TECHNOLOGY, SEMICONDUCTOR SENSOR, INFRARED (IR) SPECTROSCOPY, AND OTHERS), BY APPLICAT ... Read More

• Cystic Fibrosis - Pipeline Insights, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,500

  Cystic Fibrosis - Pipeline Insights, 2022 DelveInsight’s, “Cystic Fibrosis - Pipeline Insight, 2022,” report provides comprehensive insights about 75+ companies and 80+ pipeline drugs in Cystic Fibrosis pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stag ... Read More

• Pulmonary embolism - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 1,250

  Pulmonary embolism - Pipeline Insight, 2022 DelveInsight’s, “Pulmonary embolism - Pipeline Insight, 2022,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Pulmonary embolism pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinic ... Read More

• Lung Adenocarcinoma - Pipeline Insight, 2022

  Nov 01, 2022  |  Published by: DelveInsight  |  USD 2,000

  Lung Adenocarcinoma - Pipeline Insight, 2022 DelveInsight’s, “Lung Adenocarcinoma - Pipeline Insight, 2022,” report provides comprehensive insights about 25+ companies and 25+ pipeline drugs in Lung Adenocarcinoma pipeline landscape. It covers the pipeline drug profiles, including clinical and noncl ... Read More

• Progressive Pulmonary Fibrosis (PPF) - Market Insights, Epidemiology, and Market Forecast–2032

  Sep 01, 2022  |  Published by: DelveInsight  |  USD 7,500

  Progressive Pulmonary Fibrosis (PPF) - Market Insights, Epidemiology, and Market Forecast–2032 DelveInsight’s ‘Progressive pulmonary fibrosis (PPF) - Market Insights, Epidemiology, and Market Forecast–2032’ report deliver an in-depth understanding of the Progressive pulmonary fibrosis (PPF), histori ... Read More

< prev 1 2 3 4 5 next >